Caris Life Sciences Inc. (CAI:NASDAQ) closed at $32.00 on October 23, 2026, up 0.91% on the day. The stock trades 3.4% below its 52-week high of $33.13 and 125.5% above its 52-week low of $14.19. Over the past year, it gained 3.0%. Caris Life Sciences Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CAI closed higher on 121 days (48%). Its best day was August 6, 2026 (+21.58%) and its worst was May 8, 2026 (-18.60%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 2 times.
Caris Life Sciences is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer. We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Our current commercial product portfolio is focused on oncology and consists of MI Profile, our tissue-based molecular profiling solution that has generated the majority of our revenue to date, and Caris Assure, our novel, universal blood-based molecular profiling solution that was broadly launched in the first quarter of 2024 for therapy selection.
Find more stocks like CAI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.